2022 2021 2020 2019 2018 2017 2016 2015 2023 Immune Monitor - May Immune Monitor - April Immune Monitor - March Immune Monitor - January/February 2022 Immune Monitor - December Immune Monitor - November Immune Monitor - October Immune...
SITC leaders have prioritized Adverse Events Reporting, Clinical Trial Design/Endpoints and Combination Approaches in approaching regulatory issues relating to the field of cancer immunotherapy. Society for Immunotherapy of Cancer (SITC) leaders have prioritized the following areas of focus in...
SITC Co-Hosts Briefing on “The Promise of Cancer Immunotherapy” In collaboration with the House Cancer Caucus, the Society for Immunotherapy of Cancer (SITC) co-hosted a congressional briefing, “The Promise of Cancer Immunotherapy,” on Wednesday, Oct. 30, 2019, in the Rayburn House Office...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us